Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have received a consensus rating of “Buy” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price […]
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $32.63, but opened at $31.63. Dyne Therapeutics shares last traded at $31.07, with a volume of 1,011,286 shares trading hands. Wall Street Analysts Forecast Growth A number of research firms have commented on […]
Dyne Therapeutics (NASDAQ:DYN) Earns Buy Rating from Chardan Capital theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Dyne Therapeutics (NASDAQ:DYN) Stock Rating Reaffirmed by Chardan Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Morgan Stanley started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “overweight” rating and a $40.00 price target on the stock. Morgan Stanley’s price target indicates a potential upside of 57.11% from the company’s previous close. A number of other […]